Meeting increased demands on cell-based processes by using defined media supplements

BioProcess International

Volumn 9, Issue 8, 2011, Pages 48-58

  Dimasi, Luke ^a  

^a Novozymes Biopharma DK A S   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL CULTURE; CELL THERAPY; CRYOPRESERVATION; CULTURE MEDIUM; DRUG INDUSTRY; FINANCIAL MANAGEMENT; FREEZING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; NONHUMAN; QUALITY CONTROL;

EID: 80053213533     PISSN: 15426319     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Article

References (12)

1. Grillberger L, et al. Emerging Trends in Plasma Free Manufacturing of Recombinant Protein Therapeutics Expressed in Mammalian Cells. Biotechnol. J. 4(2) 2009: 186-201.
2. Van der Valk J, et al. Optimization of Chemically Defined Cell Culture Media: Replacing Fetal Bovine Serum in Mammalian In Vitro Methods. Toxicol. in Vitro 24(4) 2010: 1053-1063.
3. Butler M. Animal Cell Cultures: Recent Achievements and Perspectives in the Production of Biopharmaceuticals. Appl. Microbiol. Biotechnol. 68(3) 2005: 283-291. (Pubitemid 41159998)
4. Jayme DW, Smith SR. Media Formulation Options and Manufacturing Process Controls to Safeguard Against Introduction of Animal Origin Contaminants in Animal Cell Culture. Cytotechnol. 33(1) 2000: 27-36.
5. Petiot E, et al. Rapid Screening of Serum-Free Media for the Growth of Adherent Vero Cells By Using a Small-Scale and Non-Invasive Tool. Appl. Biochem. Biotechnol. 160(6) 2010: 1600-1615.
6. Butler M, et al. Application of a Serum Free Medium for the Growth of Vero Cells and the Production of Reovirus. Biotechnol. Prog. 16(5) 2000: 854-858.
7. Van Wielink R, et al. Adaptation of a Madin-Darby Canine Kidney Cell Line to Suspension Growth in Serum-Free Media and Comparison of Its Ability to Produce Avian Influenza Virus to Vero and BHK21 Cell Lines. J. Virol. Meth. 171(1) 2010: 53-60.
8. Buckler A, Al-Rubeai M. Effects of Serum and Growth Factors on HEK 293 Proliferation and Adenovirus Productivity. Animal Cell Technology: Basic & Applied Aspects, Vol. 14. Iijima S, Nishijima K, Eds. Springer: The Netherlands, 2008: 19-23.
9. Horvath B, Mun M, Laird MW. Characterization of a Monoclonal Antibody Cell Culture Production Process Using a Quality By Design Approach. Mol. Biotechnol. 2010: 1-4.
10. ICH Q8(R2): Pharmaceutical Development. US Fed. Reg. 71(98); www.ich.org/fileadmin/Public-Web-Site/ICH-Products/Guidelines/Quality/Q8-R1/ Step4/Q8-R2-Guideline.pdf.
11. Grosvenor S. The Role of Media Development in Process Optimization: An Historical Perspective. BioPharm Int. June 2008.
12. Lanan M. QbD for Raw Materials. Quality by Design for Biopharmaceuticals: Perspectives and Case Studies. Wiley Interscience: Hoboken, NJ, 2009: 193-210.